The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service-Reference-Cited by-同舟云学术

The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service

Published:2010-03-10 Issue:4 Volume:105 Page:732-739
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:

Author:

Oliver Phillip,Keen Jenny,Rowse Georgina,Ewins Elizabeth,Griffiths Laura,Mathers Nigel

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1360-0443.2009.02856.x/fullpdf

Reference21 articles.

1. One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme;Hutchinson;Addiction,2000

2. Reductions in criminal activity after addiction treatment: 5 year follow-up;Gossop;Drug Alcohol Depend,2005

3. Property crime and income generation by heroin users;Maher;Aust NZ J Criminol,2002

4. The day-to-day criminality of heroin addicts in Baltimore-a study in the continuity of offences rates;Ball;Drug Alcohol Depend,1992

5. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: a meta-analysis;Marsch;Addiction,1988

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression, anxiety, and poor well-being at discharge from psychiatric hospitals: prevalence and risk factors;Frontiers in Psychiatry;2024-07-11

2. Substance use treatment completion and criminal justice system contact in Chile: A retrospective, linked data cohort study;Addiction;2024-03-26

3. Status after Hospital Discharge: An Observational Study of the Progression of Patients’ Mental Health Symptoms Six Weeks after Hospital Discharge;Journal of Clinical Medicine;2023-12-07

4. The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV;Drug and Alcohol Dependence Reports;2023-06

5. History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder;Drug and Alcohol Dependence Reports;2023-03